Lipid nanoparticles in anti-breast cancer drug delivery systems and drug-membrane interactions
Current anticancer drugs are plagued with lack of sustained effect and poor delivery. Many current studies focus on the use of drug carriers, particularly lipid nanoparticles as new drug delivery systems. In this study, a nanostructured lipid carrier (NLC) was formulated to serve as a carrier...
محفوظ في:
المؤلف الرئيسي: | How, Chee Wun |
---|---|
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2014
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://psasir.upm.edu.my/id/eprint/70806/1/FPV%202014%2012%20-%20IR.pdf |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Drug delivery systems based on iron oxide magnetite-layered double hydroxide nanoparticles for liver anti-cancer drugs
بواسطة: Ebadi, Mona
منشور في: (2021) -
Development of multifunctional drug delivery systems based on virus-like nanoparticles for cancer targeting drug delivery
بواسطة: Biabanikhankahdani, Roya
منشور في: (2017) -
Solid Lipid Nanoparticles As Drug
Carriers For Atovaquone
بواسطة: Mohtar, Noratiqah
منشور في: (2013) -
Formulation and characterization of beeswax/rosemary oil nanostructured lipid carrier for drug delivery system /
بواسطة: Farhanim Mohd Latif
منشور في: (2021) -
Development and evaluation of sustained drug delivery system of imatinib mesylate and its in-vitro effect in breast cancer cell lines /
بواسطة: Kadivar, Ali
منشور في: (2019)